Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
55.24 USD | -1.47% | -6.72% | -30.08% |
07:56pm | Sector Update: Health Care Stocks Softer Tuesday Afternoon | MT |
06:53pm | Ohio Supreme Court Rules in Favor of Pharmacies in Opioid Crisis Case | MT |
Capitalization | 70.56B 67.16B 62.24B 55.36B 99.93B 5,988B 111B 775B 286B 2,459B 265B 259B 10,729B | P/E ratio 2024 * |
18.3x | P/E ratio 2025 * | 10.8x |
---|---|---|---|---|---|
Enterprise value | 123B 118B 109B 96.87B 175B 10,478B 194B 1,356B 501B 4,303B 464B 454B 18,776B | EV / Sales 2024 * |
0.33x | EV / Sales 2025 * | 0.31x |
Free-Float |
70.71% | Yield 2024 * |
4.73% | Yield 2025 * | 4.41% |
Last Transcript: CVS Health Corporation
1 day | -1.36% | ||
1 week | -6.24% | ||
Current month | -7.28% | ||
1 month | -0.56% | ||
3 months | -2.54% | ||
6 months | -7.94% | ||
Current year | -29.72% |
Director | Title | Age | Since |
---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 60 | 2024-10-16 |
Prem Shah
PSD | President | - | 2024-11-05 |
Thomas Cowhey
DFI | Director of Finance/CFO | 51 | 2023-10-12 |
Manager | Title | Age | Since |
---|---|---|---|
C. Brown
BRD | Director/Board Member | 72 | 2007-02-28 |
Director/Board Member | 73 | 2007-02-28 | |
Anne Finucane
BRD | Director/Board Member | 71 | 2011-01-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.92% | 20 M€ | +16.38% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
-1.41% | -6.24% | -24.76% | -43.87% | 70.56B | ||
+0.19% | -2.32% | +21.93% | +31.17% | 80.68B | ||
+0.80% | +8.74% | +6.81% | +85.80% | 27.83B | ||
-0.68% | -1.26% | +194.59% | +86.81% | 22.15B | ||
+0.44% | +0.06% | +19.96% | -0.70% | 20.11B | ||
-0.10% | -1.90% | +9.18% | -18.17% | 19.74B | ||
+0.62% | -1.39% | +16.62% | -0.23% | 17.66B | ||
-0.33% | +2.34% | +18.38% | -15.83% | 14.16B | ||
-0.34% | +0.06% | +96.67% | +86.38% | 13.41B | ||
-2.34% | -6.04% | +44.06% | +45.64% | 12.96B | ||
Average | -0.35% | -0.41% | +40.34% | +25.70% | 29.93B | |
Weighted average by Cap. | -0.34% | -1.50% | +25.15% | +16.31% |
2024 * | 2025 * | |
---|---|---|
Net sales | 372B 354B 328B 292B 527B 31,559B 584B 4,084B 1,508B 12,958B 1,396B 1,366B 56,549B | 387B 368B 341B 303B 548B 32,828B 607B 4,249B 1,568B 13,479B 1,452B 1,421B 58,823B |
Net income | 4.3B 4.09B 3.79B 3.37B 6.08B 364B 6.74B 47.17B 17.41B 150B 16.13B 15.78B 653B | 6.64B 6.32B 5.86B 5.21B 9.4B 563B 10.42B 72.92B 26.92B 231B 24.93B 24.39B 1,010B |
Net Debt | 52.92B 50.37B 46.67B 41.51B 74.94B 4,491B 83.05B 581B 215B 1,844B 199B 194B 8,047B | 50.18B 47.77B 44.27B 39.37B 71.07B 4,259B 78.76B 551B 203B 1,749B 188B 184B 7,631B |
Date | Price | Change | Volume |
---|---|---|---|
24-12-10 | 55.24 $ | -1.47% | 9,583,143 |
24-12-09 | 56.07 $ | +1.41% | 11,534,951 |
24-12-06 | 55.29 $ | -2.76% | 9,635,184 |
24-12-05 | 56.86 $ | -2.05% | 9,063,465 |
24-12-04 | 58.05 $ | -1.93% | 7,953,786 |
Delayed Quote Nyse, December 10, 2024 at 03:01 pm EST
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- CVS Stock